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The present investigation had its origin in the suggestion that the 
blood of the emergent vein of the organ or organs in which platelet 
production is taking place should show a higher platelet count than 
the venous blood of other organs.  In order to carry out this idea it 
was essential to find a satisfactory method of counting both platelets 
and erythrocytes  in samples of blood removed from the veins by means 
of a syringe.  Such a method was devised.  It is described in detail 
below.  In applying this method to various arteries and veins it was 
found that the platelet count, relative to the number of erythrocytes, 
was, in general, higher in the arteries than in the veins, indicating  an 
increase  in  the  number of platelets  during  the  passage of  the  blood 
through the lungs.  This point,  therefore, was made the subject of a 
special study by experimental and histological methods, the results of 
which are given in this paper. 
Methods 
Removal of Samples of Blood.--For this purpose 0.1 cc. of blood was taken from 
an artery or vein by means of a 0.25 cc. tuberculin syringe (B-D).  The syringes 
used were calibrated with mercury, but the graduation as given by the makers was 
found to be correct.  In these syringes the 0.25 cc. is divided into 25 equal parts, 
each representing 0.01 cc.  In taking a sample of blood the syringe with needle 
attached was filled with the diluting mixture to mark 15.  The needle (No. 24) 
was then inserted into the vessel and blood was drawn to mark 25, giving, there- 
fore, 0.1 cc. of blood.  The contents of the syringe were emptied into 39 cc. of the 
diluting  mixture and  the  syringe was filled  and  emptied  three  times with  the 
diluting mixture, so that the final dilution of the blood was 0.1 cc. in 40 cc. of the 
mixture, or 1 to 400.  This mixture was stirred thoroughly for 5 minutes with an 
electric stirrer, the wide paddies of which were coated with bakelite varnish, and 
samples were then taken for the counting chamber by means of an appropriate 
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capillary tube.  A count was made first of the erythrocytes in 10 or 15 of the small 
squares (improved Neubauer ruling).  This gave time for the platelets to settle 
and they were then counted in the entire central ruled square millimeter.  In this 
way an absolute count was obtained of both the erythrocytes and the platelets, and 
the ratio of one to the other could be determined. 
The Diluting Mixture.--Platelets are well preserved by a number of solutions, 
such as sodium metaphosphate or sodium citrate or fluoride, but for our purpose 
such solutions were not usable owing to the fact that in the counting chamber there 
was more or less rapid hemolysis of the erythrocytes, the "contact hemolysis" of 
Fenn.  This hemolysis not only prevented accurate counting of the erythrocytes, 
which was desirable for our purpose, but interfered also with counting of the plate- 
lets, especially in  the blood of the cat with its small erythrocytes, owing to the 
fact  that  particles given off from  these latter or their  "ghosts"  simulated the 
appearance of platelets and made the count uncertain.  The mixture which proved 
to be most satisfactory for our purpose in preserving both platelets and erythro- 
cytes was a buffer solution of phosphates, pH 7.3, to which was added heparin dis- 
solved in a  1.5 per cent solution of sodium chloride.  We designate this mixture 
as a  heparinized buffer solution.  For the blood of cats and dogs the following 
formula was used. 
NaCI, 1.5 per cent solution  ........................................  50 cc. 
Nag-IPO, (11.876 gin. per liter) .....................................  40  " 
KH2PO4 (9.078  ......  ) ....................................  10  " 
Heparin (crude, Hynson, Westcott, and Dunning) ...................  60 mg. 
The  heparin  is dissolved in  the  mixture  of  salts which  is  then  filtered.  The 
filtrate is  boiled gently  for  a  few  minutes,  cooled, and centrifugalized at high 
speed for  15 minutes in sterile centrifugal tubes.  The solution decanted off is 
ready for use.  Unless kept in the ice box it should be used within a  short time 
since on standing bacteria develop.  Suspended particles and bacteria interfere 
with the accuracy of the platelet count, hence the necessity of centrifugalizing the 
mixture and sterilizing the syringes and all the containers.  The counting chamber 
should be cleaned carefully before using.  We have found it best to wash thor- 
oughly with water and then very freely with alcohol, using a  cloth without lint. 
While ordinarily one can distinguish between platelets and foreign particles, or 
minute droplets adhering to the glass, yet contaminations of this kind or the pres- 
ence of bacteria may make a  count unsatisfactory or impossible.  The diluting 
mixture may be kept in the ice box for long periods, but should be boiled and 
centrifugalized before using.  It is quite possible to use the mixture two or more 
times.  In this case the liquid with its contained sample of blood is centrifugalized, 
decanted, boiled, and again centrifugalized.  Any loss of liquid is made good by 
the addition of water.  If not used at once it should be kept in a refrigerator and 
just before using should again be boiled and centrifugalized.  Stock mixtures of 
the  saline and  phosphates  may  be  made  and  used  over long periods.  When 
counts were made upon human blood the formula was modified by using a  2 per W.  H.  HOWELL  AND  D.  D.  DONAHUE  179 
cent solution of sodium chloride in place of the 1.5 per cent solution, and substi- 
tuting K2HPO4 for NaeHPO4. 
Histological Methods.--In  studying platelet  formation in the lungs and other 
tissues no success followed the use of material preserved in a Zenker mixture or in 
mercuric chloride or picroformol solutions.  When the material was preserved in 
Dominici's solution and the sections were stained with a modified Wright's stain 
excellent results were obtained. 1  In fixing the lung tissue the animal was allowed 
to bleed to death and the Dominici solution was injected under low pressure either 
into the pulmonary artery or the trachea.  Pieces of the tissue were then cut out 
and placed in the Dominici solution for ~  hour, and then passed through graded 
alcohols, 50 to 100 per cent, imbedded in paraffin, and cut in sections of 5 to 7#. 
The sections fixed on the slide were stained in the Wright's mixture according to 
the procedure below.  To obtain a  good differentiation of platelets and platelet 
material it was found desirable to treat the stained section for a brief time with very 
dilute acid.  In a  successful preparation  the platelets stand out with great dis- 
tinctness owing to the characteristic brilliant color of the contained granules.  The 
steps in the process of staining the sections were as follows: (1) xylene; (2) butyl 
alcohol; (3)  methyl alcohol; (4)  Wright stain for 30 seconds; (5)  add  twice the 
amount of water and allow to stand under cover for 25 minutes; (6) wash in water; 
(7)  immerse in dilute acid solution (3 drops glacial acetic acid to 500 cc. water) 
for 20 to 30 seconds, until blue coloring matter begins to come off in clouds; (8) 
immerse momentarily in alkaline solution (sodium bicarbonate 0.25 per cent) and 
then in water for 2 minutes.  The specimen may now be passed through acetone 
and xylene and be mounted, but experience has shown that a better differentiation 
of platelets is obtained if the process is repeated.  From the water the section is 
treated with methyl alcohol which decolorizes it more or less completely, and then 
steps 4, 5, 6, 7, and 8 are repeated.  From the water the specimen, after removal 
of surplus water from the slide,  is transferred to acetone, xylene, and mounted in 
balsam. 
The Platelet Count in Arterial and Venous Blood 
By  the  method  described  specimens  of  arterial  and  venous  blood 
were taken  as nearly simultaneously  as possible from various arteries 
and  veins,  chiefly  from  the  carotid  and  jugular,  the  femoral  artery 
and vein, and the pulmonary artery and aorta at the base of the heart. 
1 The Dominici fixing solution was prepared according to the formula given in 
Folia haematol., 1905, 2~ 219.  Downey's solution, 10 per cent formalin in phys- 
iological salt solution saturated  with HgCI~, also gives good results,  but in our 
experience the platelet material does not stain so well as after Dominici solution. 
The Wright's stain used by us was prepared by Hynson, Westcott, and Dunning, 
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Cats were used  in most of the experiments,  anesthetized  with ether,  sodium 
luminal,  or sodium amytal.  The last named is preferable,  using  60 to 100 rag. 
per kilo injected  intraperitoneally.  Counts were made independently  by each of 
us.  Successive counts on the same mixture of blood and diluting solution showed 
variations of greater or less magnitude.  Some idea of the extent of these varia- 
tions is given by the following series made upon a specimen from the femoral vein 
of a normal cat under ether.  Before each count the mixture was stirred  by the 
electric  stirrer. 
Observer 1 
Observer 2 
First  count 
Second  " 
Third  " 
Average  ........ 
First  count 
Second  " 
Third  " 
Fourth  " 
Fifth  " 
Average.. 
Erythrocytes 
9,730,000 
9,210,000 
9,560,000 
9,500,000 
9,940,000 
9,800,000 
9,800,000 
9,680,000 
9,480,000 
9,740,000 
Platelets 
288,000 
292,000 
292,000 
290,000  Ratio 1:32.8 
296,000 
284,000 
282,000 
294,000 
288,000 
289,000  Ratio 1:33.7 
Averaging the two results the count would be recorded as erythrocytes 9,620,000, 
platelets,  289,500, giving a  ratio of 1 platelet  to 33.2 erythrocytes.  When  the 
technique is good the method gives concordant results, but in platelet counting the 
greatest source of error,  in our experience, lies in the factors already referred  to, 
namely, the presence  of foreign particles,  or air droplets  on the surface  of the 
counting chamber.  When a  specimen of this kind was encountered  it was dis- 
carded  and a new one was made.  In comparing  the arterial and venous counts 
dependence was placed upon the ratio of platelets  to erythrocytes rather than upon 
the absolute counts, since in spite of the care taken to obtain equal specimens some 
slight  variations in  the amount of blood  removed by the syringe  were at times 
unavoidable. 
Comparisons between arterial and venous blood in normal anesthe- 
tized cats were made in four series occurring at different times during 
the investigation, and amounting to a total of 89 animals.  The figures 
for each of these cases are given for the first three  series  in order to 
illustrate  the  variations  found  in  normal  animals.  When  the  ratio 
of platelets to erythrocytes in the companion artery and vein differed 
by less than one the coufit was considered as equal in the two vessels 
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Series I  Series  I--Continued 
Experi- 
ment 
1934 
Apr.  5 i A. left aur. 
V. right aur. 
"  9  A. sup. mes. 
V. portal 
"  12  [ A. carotid 
i V. portal 
"  17  A. aorta 
i V. splenic 
"  19  A. left aur. 
V. pulm. art. 
May  3  A. left aur. 
i V. pulm. art. 
"  7  A. carotid 
V. jugular 
"  8  A. left. aur. 
V. pulm. art. 
"  9  A. carotid 
V. jugular 
14  A. carotid 
V. jugular 
"  23  A. carotid 
V. jugular 
"  25  A. carotid 
V. jugular 
June  4  A. carotid 
V. jugular 
"  7  A. aorta 
V. sup. mes. 
"  11  A. aorta 
V. pulm. art, 
"  12  A. aorta 
V. splenic 
"  13  A. carotid 
V. jugular 
R.B.C.  Platelets  Ratio  Experi-  ment 
1934 
7,640,00£  554,000  1:13.8  June 20  A. aorta 
7,150,00C  479,00(  1:14.$  V, pulm. art. 
7,380,00(]  557,00(  I:13A  "  27  A. aorta 
7,970,00(~  543,00(  1:14A  V. pulm. art. 
11,180,000  576,00C  1:19.4  "  28  A. aorta 
9,670,000  502,00G  1:19.2  V. pulm. art. 
8,170,000  510,00(]  1:16 
8,050,000  460,00(]  1:17.5 
7,310,000  475,000  1:15.4 
7,270,000  427,000  l:17.G 
6,250,000  386,000  1:16.1 
6,220,000  329,000  1:18.~ 
6,720,000  756,00G  1:8.8 
6,750,000  530,000 1:12.7 
5,570,000  554,00(3 1:10.1 
6,030,000  535,00C  t:11.3 
7,930,000  462,00G  1:17.1 
8,550,000  399,00G  1:21.3 
4,390,000  142,00C  t:30A 
4,380,000  138,00C  1:31.7 
5,950,000  295,00~  1:20.1 
5,730,000  258,000  1:22.2 
8,947,000  735,000  1:12.1 
8,405,000  595,00(3 1:14.1 
11,220,000  333,00(]  1:33.~ 
10,260,000  316,00G  1:32,1 
8,950,000  337,50(3 1:26,5 
8,940,000  343,00~ 1:26.1 
9,000,000  262,00(]  1:34.3 
8,897,000  238,50C  1:37.3 
7,420,000  534,500  1:13.8 
7,140,000  515,000  1:13.8 
7,626,000 1,001,00C  t:7.6 
7,726,000  902,00(]  t:8.6 
R.B.C. 
7,708,00C 
7,618,00C 
5,685,00C 
6,070,000 
5,935,000 
6, 235,000 
Plate- 
lets 
579,00C 
t72,000 
613,000 
517,000 
351,000 
350,000 
Series II 
1934 
Oct. 
"  9 
"  11 
"  31 
Nov.  3 
"  6 
"  8 
"  12 
"  14 
"  16 
"  20 
"  30 
5  A. carotid 
v.  juguhr 
5  A. carotid 
V. jugular 
A. carotid 
V. jugular 
A. carotid 
V. jugular 
A. aorta 
V. pulm. art. 
A. aorta 
V. pulm. art. 
A, carotid 
V. jugular 
A, aorta 
V, pnim. art. 
A, aorta 
V, sup. rues. 
A, aorta 
V, sup. mes. 
A. aorta 
V. pulm. art. 
A. aorta 
V. sup. mes. 
A. aorta 
V. pulm. art. 
6,160,000 
6,150,000 
7,520,000 
6,475,000 
11,290,000 
10,250,000 
7,170,000 
6,850,000 
8,230,000 
9, 660,000 
8,572,000 
7,700,000 
6,240,000 
6, 290,000 
8,010,000 
7,990,000 
9,060,000 
9,330,000 
7,630,000 
6,580,000 
6,280,000 
6,380,000 
9,360,000 
8,930,000 
5,920,000 
5,140,000 
Ratio 
1:13.3 
1:16.1 
1:9.3 
1:11.7 
1:16.8 
1:17.8 
311,000  1:19.8 
234,000  1:26.2 
408,000  1:18.4 
324,000  1:20.0 
454,000  [:24.8 
470,000  1:21.8 
366,000  1:19.3 
351,000  1:19.5 
486,000  1:16.7 
489,000  1:19.7 
524,000  1:16.3 
428,000  1:18.0 
465,000  1:13.4 
348,000  1:18.0 
528,000  1:15.2 
416,000  1:19.2 
626,000  1:14.4 
526,000  1:17.7 
572,000  .:13.3 
500,000 1:13.1 
444,000  1:14.3 
360,000 1:17.7 
506,000  1:18.5 
398,000  1:22.4 
628,000  1:9.4 
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TABLE  I--Concluded 
Series III 
Experi- 
ment 
1935 
Mar. 12  A. aorta 
V. pulm. art. 
Apr.  1  A. aorta 
V. pulm. art. 
June 29  A. femoral 
V. femoral 
July  I  A, aorta 
V. pulm. art. 
"  1  A. aorta 
V. pulm.  art. [ 
"  6  A. femoral 
V. femoral 
R.B.C. 
6,720,000 
6,620,000 
4,060,000 
4,200,000 
9,860,000 
9,350,000 
7,580,00( 
7,830,00( 
7,810,01K 
7,200,00( 
5,820, 00( 
5,420,00C 
Platelets  Ratio 
416,000  1:16.1 
352,000  1:18.8 
138,000  1:29.2 
142,000  1:29A 
370,0001:26.¢ 
309,000  1:30.~ 
425,000  ~1:17.~ 
389,000  !1:20.( 
405,000  1:19.~ 
315,000  1:22A 
422,000  t:13A 
346,000  !1:15.~ 
Series III--Continued 
Experi- 
ment 
1935 
July  8  A. femoral 
V. femoral 
"  15  A. femoral 
V. femoral 
"  22  A. femoral 
V. femoral 
"  23  A. femoral 
V. femoral 
"  24  A. femoral 
V. femoral 
R.B.C. 
4,790,00( 
4,540,00( 
10,450,00( 
10,150,000 
5,840,00C 
5,890,00C 
8,580,000 
8,710,000 
8,580,000 
8,730,000 
Plate- 
lets 
310,000 
255,00C 
271,000 
253,000 
1317,000 
291,000 
511,000 
465,000 
443,000 
417,000 
Ratio 
1:15.4 
1:17.[ 
1:38.5 
1:40.! 
1:18.4 
1:20.2 
1:16.~ 
1:18.7 
1:19,4 
1:20.9 
The results show that of the total of forty-four observations thirty- 
four or 77.3 per cent gave a higher count of platelets in the artery than 
in the vein; eight or 18.2 per cent gave an equal count for artery and 
vein, and two or 4.5 per cent showed a higher count in the vein.  It is 
probable that series III gives the most reliable count, since the condi- 
tions were more favorable and there had been greater experience with 
the technique.  In this series only one of the eleven observations failed 
to show a larger number of platelets in the arterial blood. 
Series IV was a miscellaneous group in which specimens were taken 
from artery and vein before or after various experimental procedures. 
Forty-five comparisons were made.  Of these 75.5 per cent showed a 
larger  platelet  count in the  artery.  In  22.2 per cent the  count  was 
approximately the same in artery and vein.  In one case only was the 
count larger in the vein. 
We have not found in the literature any reference by other observers to a pos- 
sible production of platelets  in  the lungs,  except an  interesting  observation  re- 
ported by Simpson.  In her study of the experimental production of macrophages 
in  the  circulating  blood she  states  that  in  certain  cases,  after  the injection  of 
colloidal solutions, there was an enormous reduction or practical disappearance of 
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the presence of a normal number.  The author suggests that "a remarkable process 
goes on in  the lung,  whereby the distinctly abnormal venous blood is rendered 
normal by the time it reaches the left ventricle."  We have tried to repeat this 
interesting observation upon cats by the use of India ink, given in single large 
doses or in smaller doses over a number of days, but so far have been unsuccessful. 
H6ngo and Ma6da in their paper upon hematopoiesis  in the lungs report that in 
rabbits after intravenous injection of colloidal iodine or silver, especially if accom- 
panied by hemorrhage,  a condition of myeloid metaplasia develops in the lungs. 
Lung smears show the characteristics of marrow smears.  They state that similar 
results were obtained by Iishimas.  They make no reference, however, to platelet 
production. 
Occasional  references  are found in  the literature to  comparative counts of 
platelets in arterie~ and veins, especially the splenic artery and vein in connection 
with the supposed function of the spleen as a destroyer of platelets.  The general 
view has been that the splenic vein contains fewer platelets (Galloway).  The only 
report of comparative observations on a larger scale that we have been able to find 
is in the paper published by Holloway and Blackford.  They report experiments 
upon some  twenty dogs in which  comparisons  were made between the splenic 
artery and vein, the jugular and carotid, and the femoral artery and vein.  With 
few exceptions their counts showed a larger number of platelets in the veins, a result 
just the reverse of ours.  But it may be said that the method used by them to get 
their specimens of blood could scarcely be expected to give accurate results for 
platelets.  They punctured the artery or vein and took specimens from the blood 
as it flowed out.  Some of their results showed differences  that in themselves 
would seem to indicate the inadequacy of the method, e.g., femoral artery, 75,000, 
femoral vein, 342,000. 
Comparison of Counts in Artery and Vein under Conditions Causing a 
Reduction in Platelets.--The conclusion suggested by the above obser- 
vations on normal  animals  is  strengthened by the  results of experi- 
ments in which the number of circulating platelets was first reduced by 
various methods.  The most direct of these methods, perhaps, is the 
one used by Duke in which the animal is bled repeatedly in small lots 
and  the  blood  after  defibrination  is  reinjected.  Cats  upon  which 
this  operation  had  been  carried  out  were  examined  in  some  cases 
shortly after the operation, in other cases  1 day, 3,  and 5  days after 
the  operation.  Brief reports  are  given of  the  results  obtained  (see 
Table II). 
In  all of these  experiments the number of platelets  in  the  artery 
was  distinctly  greater  than  in  the  vein.  The  difference was  most 
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shortly after the operation or within 24 hours, owing to the reduced 
number of platelets.  After 3 to 5 days when the regeneration of the 
platelets, which Bunting has shown precedes that of the erythrocytes, 
had made considerable progress toward normal, the difference between 
artery and vein approached that found under normal conditions. 
TABLE  II 
Defibrination 
(1)  Oct.  9,  1954.  Cat,  bled  from ca- 
rotid, 4 lots of 25 cc. each.  Blood 
defihrinated  and reinjected 
(2)  Oct.  23,  1934.  Cat, bled from ca- 
rotid, 4 lots of 25 cc. each.  Blood 
defibrinated  and reinieeted 
(3)  Oct.  25,  1934.  Cat, bled  from ca- 
rotid, 7 lots of 25 cc. each.  Blood 
defibrlnated  and reinjected 
(4)  Feb. 5,  1935.  Cat,  bled  from  ca- 
rotid, 7 lots of 25 cc. each.  Blood 
defihrinated  and reinjected 
(5)  Feb.  8,  1935.  Cat,  bled  from ca- 
rotid, 4 lots of 50 cc. each.  Blood 
defibrinated  and reinjected 
(6l  Feb.  15,  1935.  Cat, bled  from ca- 
rotid, 4 lots of 50 cc. each.  Blood 
defibrinated  and reinjected 
(7)  Mar. 27, 1935.  Cat, bled from ca- 
rotid, 41otsofS0cc. each.  Blood 
defibrinated  and reinjeeted 
(8)  May 8, 1935.  Cat, bled from femo- 
ral, 5 lots  of 50 ce. each.  Blood 
defihrinated  and rein/ected 
Time after bleeding  R.B.C.  Plate-  lets  Ratl 
Before bleeding, jugular 
After bleeding  ~  hr. 
Before bleeding, jugular 
After bleeding  ~  hr. 
Before bleeding, jugular 
After bleeding 1/~ hr. 
10,250,00C  &70,000 1:21. 
Artery  9,590,00C  294,00~ 1:32. 
Vein  9,470,00C  ~28,00~ 1:41. 
6,385,00C  393,00(] 1:16. 
Artery  9,430,00C  298,00C 1:31. 
Vein  9,230,00C  244,00~ 1:37. 
7,600,00C  536,000 1:14 
Artery  7,235,00C 228,00~  1:31. 
Vein  7,900,00~  202,00(] 1:39. 
After bleeding 24 hrs.  Artery  5,600,00C  112,000 1:50 
Vein  5,680,00C  88,000  1:64. 
Before bleeding, jugular  9,026, 00C 480 L  000 1:18. 
After bleeding 72 hrs.  Artery  6,360,00C  282,000  1:22. 
Vein  6,200,00C  256,000  1:24. 
Before bleeding, jugular  9,820,000 210,000  1:47 
End of bleeding, carotid  7,840,000  56,0001:14( 
After bleeding  120 hrs.  Artery  5,860,000 292,000  1:20 
Vein  5,580,000 240,000  1:23. 
Before bleeding, jugular  9,390,000 680,000  1:13. 
End of bleeding, carotid  6,440,000 228,000  1  : 28. 
Afterbleedlng 120hrs.  Artery  5,710,000 442,000  1:12. 
Vein  5,360,000 348,000  1:15. 
Before bleeding, femoral v.  8,500,000 362,000  1:23. 
End of bleeding, femoral a.  7,040,000 124,000  1:56. 
After bleeding, 24 hrs.  Artery  5,580,000 202,000  1:26. 
Vein  5,800,000 150,000 1:38. 
In another series  the platelets  were  reduced by  the  intravascular 
injection of saponin (Table III).  The actual effect of the saponin on 
the platelets was not determined since in these experiments a prelimi- 
nary  blood  count was omitted.  It  would seem,  however,  from the 
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ment of June 25, in which, in spite of the fact that a large dose was 
given, the number of platelets appears to have been increased.  In all 
TABLE  III 
Saponin Injections 
(1)  May  1,  1934. 
rag. per kilo 
(2)  May 10, 1934. 
per kilo 
(3)  May 14, 1934. 
rag. per kilo 
(4)  June 4,  1934. 
rag. p~ kilo 
(5)  June 25, 1934. 
mg. per kilo 
Cat, sapenin, intravenous, 0.75 
Cat, sapenin, intravenous, 1 mg. 
Cat, sapenin, intravenous, 0.75 
Cat, saponin, intravenous, 0.33 
Cat, saponin, intravenous, 1.25 
Time 
after 
injectio~ 
24 hrs. 
24 hrs. 
40  rnln, 
24 hrs. 
24 hrs. 
Artery 
Vein 
Artery 
Vein 
Artery 
Vein 
Artery 
Vein 
Artery 
Vein 
R.B.C. 
6,930,000 
7,140,000 
7,962,000 
8,185,000 
4,750,000 
4,380,000 
9,000,000 
9,663,000 
5,283,000 
5,755,000 
Platelets 
182,000 
123,000 
257,000 
209,000 
152,000 
127,000 
360,000 
266,000 
649,000 
572,000 
Ratio 
1:38.3 
1:58 
1:31 
1:39,1 
1:31.2 
1:43.4 
1:25 
1:36.3 
1:8.1 
1:10.1 
TABLE  IV 
Peptone Injections 
Platelets  Ratio 
(1)  June 21,  1934.  Cat, peptone, intravenous, 0.3 
gm. per kilo 
(2)  June 22,  1934.  Cat, peptone, intravenous, 0.3 
gin. per kilo 
(3)  July 2, 1934.  Cat, peptone, intravenous, 0.3 gin. 
per kilo 
(4)  Oct.  10,  1935.  Cat, peptone, intravenous, 0.3 
gin. per kilo 
(5)  Nov. 20,  1935.  Cat, peptone, intravenous, 0.3 
gin. per kilo 
(6)  Feb.  19,  1936.  Cat, peptone, intravenous, 0.3 
gin. per kilo 
Time  j 
after 
injection  'T 
10 
25 
10 
5 
5 
Artery 
Vein 
Artery 
Vein 
Artery 
Vein 
Artery 
Vein 
Artery 
Vein 
R.B.C. 
8,070,000 
8,490,000 
8,920,000 
9,250,000 
0,825,000 
0,540,000 
8,200,000 
8,620,000 
4,500,000 
4,240,000 
Artery  I 9,410,000 
Vein  9,610,000 
82,000 
69,000 
249,000 
189,000 
270,000 
234,000 
76,000 
54,000 
110,000 
80,000 
166,000 
140,000 
1:98.4 
1:123 
1:35.8 
1:48.9 
1:40.1 
1:45 
1:108 
1:160 
1:41 
1:53 
1:56.7 
1:68.6 
of the experiments the arteries were found to contain more platelets 
than the veins and the difference, as regards the ratio, was greater, 186  PRODUCTION  OF  BLOOD  PLATELETS  IN  LUNGS 
except  in  the  experiment of June  25,  than  was found  under  normal 
conditions. 
In a  third series the platelets were reduced by means of a  peptone 
solution made up in 0.9  per cent sodium chloride and injected intra- 
venously in amounts equal to 0.3  gm. of peptone per kilo of animal. 
In these cases the blood was examined shortly after the injection, since, 
as Pratt and others have shown, the effect of peptone upon the number 
of platelets is only transitory, largely disappearing within an hour or 
two  (Table IV). 
Comparison  of Arterial and  Venous  Blood  of Special  Regions.--The 
prevalent view that platelets are formed in the bone marrow made it 
desirable to examine the blood of the emergent veins of the long bones, 
but on account of their small size in the cat this was not practicable 
for the method we were using. 
Vena Azygos: The vena azygos, however, which brings back blood from the 
ribs and other tissues is of large size, and it would seem probable that if the red 
marrow is the sole source of platelet production the blood of this vein should show a 
larger number of platelets compared with other veins, or the arteries.  In the 
observations made upon this vein the thorax was opened along the mid-line of the 
sternum, the two lowermost ribs on the right side were cut away, and the vein was 
ligated just above the diaphragm.  A  specimen was then  taken from the vein 
where it bends over to join the superior cava.  Ten such experiments were made. 
In nine of the ten experiments the ratio of platelets to erythrocytes was lower in 
the blood of the vena azygos than in that of the left auricle or aorta.  In one the 
ratio was the same.  Hepatic Vein: In the experiments made upon this vein the 
inferior cava was ligated below the diaphragm.  The thorax was then opened and a 
specimen of blood was taken from the cava above the diaphragm.  The blood 
count from it was compared with that of a specimen from the portal vein taken 
either before or after the ligation of the inferior cava below the diaphragm.  Seven 
observations were made.  In five of them  the platelet  count  was lower in  the 
hepatic blood than in the portal blood.  In the other two  cases  the platelets  in 
the hepatic blood were slightly in excess, as judged by their ratio to the erythro- 
cytes.  The evidence, therefore, indicates that the blood loses rather than gains in 
platelets in passing through the liver.  Splenic Vein: Specimens of splenic  blood 
were taken either from the main trunk where it joins the mesenteric vein or from 
one of the smaller veins near its emergence from the spleen.  They were compared 
with specimens of arterial blood taken from the abdominal aorta.  Eleven observa- 
tions were made.  In ten of them the platelet count was lower in the splenic vein 
than in the aorta.  In the remaining case the count was approximately identical. 
Here also the evidence indicates a loss of platelets in the blood passing through the 
spleen.  Superior Mesenteric Vdn:  Comparative counts were made in ten cases W. H. HOWELL  AND  D. D. DONAHUE  187 
of specimens of blood taken from the superior mesenteric vein and the abdominal 
aorta.  In seven of them the platelet count in the vein was lower and in three the 
ratios were practically the same, indicating the probability that the blood loses 
platelets in passing through the capillaries of the intestine. 
Observations  upon  Human  Blood.--It  is  desirable,  of  course,  to 
extend these comparative counts to animals other than the cat, and, 
especially, to ascertain whether a  similar difference holds for human 
blood.  Some few observations of this kind that v~e were able to make 
may be referred to briefly in this connection.  It happens that in one 
of  the authors  the  radial  artery  of  one  wrist  is  easily  accessible 
and several counts were made upon specimens taken from this artery 
compared  with venous  blood from the  median  cubital  vein  at  the 
elbow.  Two or more  counts were made by each observer  and the 
averages were used in making the comparisons. 
1934 
Feb.  19 
"  23 
Mar. 16 
Apr. 11 
"  27 
June  8 
193$ 
July  $ 
"  22 
1936 
*Mex. 13, lla.m 
"  13,  3p.m. 
Artery 
Vein 
Artery 
Vein 
Artery 
Vein 
Artery 
Vein 
Artery 
Vein 
Artery 
Vein 
Artery 
Vein 
Artery 
Vein 
Artery 
Vein 
Artery 
Vein 
Erythrocytes  PIatelets  Ratio 
5,480,000 
5,650,000 
5,016,000 
5,451,000 
5,347,000 
3,610,000 
5,202,000 
4,843,000 
5,751,000 
5,102,000 
5,750,000 
5,270,000 
5,360,000 
6,055,000 
5,840,000 
5,890,000 
5,850,000 
5,380,000 
5,400,000 
5,216,000 
274,000 
232,000 
255,000 
245,000 
306,000 
278,000 
257,000 
240,000 
255,000 
255,000 
295,000 
192,000 
264,000 
250,000 
317,000 
291,000 
192,000 
167,000 
136,000 
137,000 
1:20 
1:24.3 
1:19.7 
1:22.2 
1:17.4 
1:20.2 
1:20.2 
1:20.1 
1:22.5 
1:20.0 
1:19.1 
1:27.4 
1:20.3 
1:24.2 
1:18.4 
1:20.2 
1:30.4 
1:32.2 
1:34.6 
1:38.0 
* The last two counts were made in connection with an experiment on the effect of 
occlusion of  the veins.  The subject was not well at the time and was subsequently sent 
to the hospital.  This fact probably accounts for the unusually low platelet count. 188  PRODUCTION  OF  BLOOD  PLATELETS  IN  LUNGS 
In eight of the ten examinations the number of platelets was larger 
in the artery, in one the count was practically the same, and in one it 
was slightly larger for the vein.  If one takes the average of the ten 
observations, as seems to be permissible, since they were made upon 
TABLE  V 
Thrombocytopenia 
(1) Jan. 24,  1934.  Female, white, 8 yrs., diagnosis, purpura hemor- 
rhagica.  At time of Observation patient much improved 
(2)  Oct. 23, 1935.  Male, white, 44 yrs., diagnosis, chronic purpura 
(3)  Nov.  18,  1935.  Male, white, 7 yrs., diagnosis, thrombocytopenic 
purpura 
(4)  Feb. 4, 1936.  Female, white, 2 yrs., diagnosis,  thrombocytopenic 
purpura.  Shortly after this observation the patient had a strepto- 
coccus infection, throat.  Following this there was a long lasting 
rise in the platelet count as follows: 
Feb. 22, 1936 
Mar. 11, 1936 
June 10, 1936 
(5)  Dec. 7, 1935.  Male, white, 33 yrs., diagnosis, hemophilia? coagula- 
tion time 26 rain. 
(6)  Oct. 26, 1935.  Male, negro, 50 yrs., diagnosis, aplastic anemia 
(7)  Feb. 8, 1936.  Male, negro, symptoms, nasal bleeding, swollen knee 
2nd examination Feb. 12, 1936 
(8)  Feb.  18,  1936.  Male, white, 6  yrs.  Previous thrombocytopenic 
patient.  Discharged Nov., 1933.  Admitted for reexamination 
Ratio 
1:15 
1:34 
1:33.2 
1:53.3 
1:60.5 
1:97.2 
1:93.4 
1:230 
1:8.8 
1:10.5 
1:9.7 
1:11.9 
1:27.9 
l:32.6 
1.: 63 
l:95.4 
[:128 
l:175 
[:14.4 
[:18.9 
[:18.8 
[:22.3 
[:13.5 
[:13.7 
the  same  individual  under  like  conditions,  we  get  the  following 
figures: 
Artery,  erythrocytes 5,499,600,  platelets 257,100,  ratio 1:21.4 
Vein,  "  5,446,700,  "  228,700,  "  1:23.8 
which indicate  a  difference  quite  comparable  to  the average result 
of the observations made upon the cat. W.  H.  HOWELL  AND  D.  D.  DONAHUE  189 
Several observations were made upon patients in the Johns Hopkins 
Hospital showing hemorrhagic conditions, chiefly cases with thrombo- 
cytopenia or purpuric symptoms.  When there was distinct thrombo- 
cytopenia the difference in count between artery and vein was quite 
marked, but the figures, as far as they go, do not support the view of 
those  who  have  suggested  that  the  low  count  is  due  to  increased 
destruction of platelets  rather than  to diminished production.  The 
specimens  of blood  were  taken  for us  by  different members  of  the 
hospital staff, arterial blood from the radial artery and venous blood 
from the median cubital vein (Table V).  With the exception of the 
last case the platelet count in the artery was larger than that in the 
vein. 
Perfusion Experiments 
In their experiments upon perfusion of the marrow of the tibia with 
oxalated saline, Drinker and Drinker comment upon the fact that in 
the  perfusate no platelets  were found.  Following  this  suggestion  a 
series of experiments was  carried out  in  which  the lungs  and  other 
organs  were  perfused  with  a  platelet-preserving  solution,  and  the 
perfusate was examined at certain intervals for its content in platelets 
and erythrocytes, and the proportion of one to the other. 
The lungs were perfused through the heart.  An inflow cannula was placed in 
the superior cava and an outflow cannula in the aorta at its origin from the heart, 
and the vena azygos and inferior cava were ligated.  The perfusing fluid used in 
all the experiments was  the saline  phosphate, pH  7.3,  described  above in the 
method for haaking platelet counts, but without the heparin.  In some experiments 
the perfusion was continuous, in others a certain volume was recirculated for a 
time and was then followed by a continuous perfusion.  It was found that this 
solution sooner or later set up an edema of the lungs which terminated the experi- 
ment.  In the later experiments this difficulty was avoided by the introduction of a 
certain amount of egg albumin in the perfusing fiquid.  The usual procedure in 
these cases was first to wash out most of the blood by passing through 200 to 300 
cc. of the saline phosphate mixture and then to substitute the albuminous mixture, 
a definite volume of which was recirculated ten to twelve times.  This was fol- 
lowed by a continflous perfusion of the saline phosphate mixture until edema began 
to develop.  Samples of the perfusate were removed at regular intervals, heparin 
was added, and the sample was put aside for examination at the end of the per- 
fusion.  At the examination each sample was mixed thoroughly by an electrical 
stirrer and from the mixture a specimen was taken by means of a capillary tube to 
fill the counting chamber.  Counts were made usually for the entire ruled area of 
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In the first series of experiments, in which the saline phosphate mixture was 
used without the addition of albumin,  comparative tests were made upon  the 
lungs, liver, kidney,  intestines, marrow, spleen, and pancreas.  The results indi- 
cated clearly that  in the lungs continuous perfusion brings out relatively more 
platelets, that is to say, the ratio of phtelets to erythrocytes increased, as the 
perfusion continued, much more markedly in the lungs than in the other organs. 
A brief record of one experiment will indicate the character of the results obtained. 
Nov.  16,  1934.  Cat, 3 kilos, under luminal.  After opening the chest speci- 
mens of arterial and venous blood were examined to determine the normal ratio 
of platelets and erythrocytes. 
Artery, aorta,  erythrocytes 6,280,000,  platelets 444,000,  ratio 1 : 14.3 
Vein, pulmonary artery,  "  6,380,000,  "  360,000,  "  1 : 17.7 
Perfusion was established through the lungs and the effluent was collected in five 
lots, each divided into four parts of 50 to 100 cc., as follows, A-1 to A-4, 400 cc.; 
B-1 to B-4, 200 cc.; C-1 to C-4, 200 cc.; D-1 to D-4, 200  cc.; E-1 to E-4, 400 cc. 
Total perfusate was  1400  cc.  An interval of 5 minutes was given between the 
collection  of  each  lot.  Artificial respiration  was  maintained  throughout  the 
experiment. 
Counts  Erythrocytes  Plate]ets  Ratio 
A-t 
A4 
B-t 
B4 
C-1 
C4 
D-I 
D4 
E-I 
E-2 
E4 
470 
142 
231 
411 
793 
16'1 
106 
71 
172 
65 
27 
65 
37 
55 
113 
373 
113 
80 
61 
170 
80 
49 
1:6.3 
1:3.8 
1:4.2 
1:3.6 
1:2,1 
1:1,4 
1:1.3 
1:1.1 
1:1 
1.2:1 
1.8:1 
The figures show that as the washing out proceeded the number of 
erythrocytes and platelets in the effluent varied irregularly, the eryth- 
rocytes showing a decreasing trend.  The ratio of platelets to erythro- 
cytes in the circulating blood before perfusion was approximately  1 
to 16, but this ratio increased more or less steadily in the effluents until 
at the end there were nearly two platelets to each erythrocyte.  The 
result would seem to indicate some kind of a supply of platelets in the 
lungs. 
Similar experiments made  upon  other  organs  gave  a  different  result.  For 
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in the circulating blood 1 to 13.  During the perfusion this ratio varied irregularly 
between 1 to 8 and 1 to 35, but at the end of the peffusion was 1 to 10. 
Spleen and Pancreas (and Part of Stomach).--Total perfusion 2 liters.  Initial 
ratio of platelets to erythrocytes in the circulating blood 1 to 20.  During the 
perfusion the ratio varied irregularly between 1 to 13 and  1 to 29.  In the last 
perfusate it was 1 to 19.5. 
Intestines.--Total perfusion 2 liters.  Initial ratio of platelets to erythrocytes 
in circulating blood 1 to 30.  During the perfusion the ratio varied between 1 to 15 
and 1 to 7.  In the last perfusate it was 1 to 18, but in the last three samples col- 
lected the platelets were so few in number, one or none in the entire ruled field of 
the counting chamber, that the ratio lost its significance.  The important fact, 
however, was the small number of platelets washed out of the tissue compared 
with the lungs. 
Tibia.--The intention in this case was to peffuse the marrow of the tibia.  The 
inflow cannula was inserted into the popliteal artery above the knee joint, and an 
attempt was made to ligate all branches except those entering the tibia.  This was 
not successful as was evident f.rom the volume of the outflow, so that the experi- 
ment gave the result of a  perfusion of the marrow  together with some of the 
muscles and tissue surrounding the tibia.  Total perfusion something less than a 
liter.  Initial ratio of platelets to erythrocytes in the circulating blood 1 to 20. 
During peffusion this ratio varied between 1 to 16 and 1 to 7.5.  In the final efflu- 
ent the ratio was 1 to 15, but here again the platelets toward the end of the per- 
fusion were so few in number that a  small difference in the count made a  large 
change in the ratio. 
Liver.--Total perfusion 1½ liters.  Inflow cannula in portal vein.  Initial ratio 
of platelets to erythrocytes in circulating blood 1 to  17.  During peffusion the 
ratio varied between 1 to 15.5 and 1 to 6.  In the final peffusate the ratio was 1 
to  8. 
In the second series of experiments the perfusion fluid containing albumin was 
employed.  As stated above the organ was first washed out with the saline phos- 
phate mixture.  This was then replaced by the  albumin mixture, 100 to 150 cc. 
of which was recirculated ten or more times.  This was followed by a continuous 
peffusion of several hundred cc. of the saline phosphate mixture.  Artificial respi- 
ration was maintained throughout the experiment.  The results in the case of the 
lungs were striking as may be seen from the data of two experiments.  Dec. 3, 
1934.  Initial perfusion with  saline phosphate mixture  500  cc.  Perfusate col- 
lected in five lots, B-1 to B-5, of 100 cc. each. 
Erythrocytes  Platelets  Ratio 
B-1  511  55  1:9.1 
B-3  535  154  1:3.4 
B-4  367  207  1:1.8 
B-5  227  133  1:1.7 192  PRODUCTION  OF  BLOOD  PLATELETS  IN  LUNGS 
The albumin-containing solution,  150  cc.,  was recirculated  ten  times  and  was 
followed by a continuous perfusion of the saline phosphate mixture, 150 cc., the 
effluent being collected in two lots, X and Y, each 75 cc. 
X 
Y 
Erythrocyte~ 
146 
46 
Platelets 
319 
177 
Ratio 
2.2:1 
3.8:1 
Jan.  2,  1935.  Lung.  Initial perfusion with  saline phosphate mixture 200  cc. 
Followed by recirculation of the albumin mixture, 150 cc., ten times.  Then con- 
tinuous perfusion of the saline phosphate, 850 cc.  This perfusate was collected in 
seventeen lots of 50 cc. each.  B-1 to B-17.  Total perfusion 1200 cc. 
B-1 
B~3 
B-5 
B-7 
B-9 
B-11 
B-13 
B-15 
Erythrocytes 
340 
29 
16 
33 
14 
4 
6 
8 
Platelets 
127 
75 
78 
81 
39 
35 
30 
38 
Ratio 
1:2,6 
2.6:1 
4.8:1 
2.15:1 
2.7:1 
8.?:1 
5:1 
4.6:1 
The results of these two experiments seem to indicate that a  source 
of platelets  exists  in  the  lungs  other  than  can  be  explained  by  the 
content  of the  circulating  blood.  A  similar experiment was  carried 
out with the liver.  While the results showed a decided increase in the 
platelet ratio the increase was not comparable to that exhibited by the 
lungs. 
Jan.  8,  1935.  Liver.  Perfusion through portal vein.  Inferior cava ligated 
below diaphragm.  Aorta and branches arising from it below diaphragm ligated. 
Initial perfusion with saline phosphate mixture 300 cc.  Followed by recirculation 
ten times of the albumin solution  and a final continuous perfusion of  1600 cc. of 
the saline phosphate solution.  Effluent of the last perfusion collected  in 100 cc. 
lots, C-1 to C-17.  Total perfusion 2150 cc. 
C-I 
C-3 
C-5 
C-7 
C-9 
C-11 
C-13 
C-15 
C-17 
Erythrocytes 
269 
268 
233 
131 
50 
24 
34 
25 
73 
Platelets 
61 
71 
48 
30 
11 
8 
11 
7 
22 
Ratio 
1:4.7 
1:3.7 
1:4.8 
1:4.4 
1:4.5 
1:3 
1:3.1 
1:3.6 
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Histology of Platelet Formation in the Lungs 
Our  experimental  results  indicated  that  platelet  formation  takes 
place in the lungs, and a  histological study of the lungs was made by 
means of sections and smears to determine if possible the source and 
mode of production of the platelets. 
Lung Smears.--Smears or impressions were made from a freshly cut surface of 
the lungs in normal animals and in animals in which the process of platelet forma- 
tion had been accelerated by previous experimental  reduction of the number of 
platelets in the circulating blood.  The smears after d.rying were stained after the 
manner of blood smears in Wright's stain.  These preparations  while interesting 
were not very informative in regard to the origin of the platelets.  In many of the 
slides numerous platelets were found, singly or in small or large groups, clearly 
marked out by their characteristic staining.  They varied greatly in size and form, 
from the typical small platelet with a diameter of 2 to 4~ to large forms the size of 
an erythrocyte or much larger.  In many cases platelet masses occurred, elongated 
or oval or circular in form.  These masses showed the characteristic  staining of 
platelets,  namely, a  bluish  ground  substance  thickly dotted  with  red-purple 
granules. 
The lung smears showed numerous so called dust cells and not infrequently  some 
of these were found to contain one or more platelets,  but after careful study of 
many preparations  we were convinced that this represented merely an occasional 
ingestion  of platelets by these  phagocytic cells and had no bearing  upon  the 
problem of platelet production. 
Lung Sections.--The lungs were preserved  in  Dominici's solution, 
injected through the pulmonary artery or trachea,  and were stained 
with Wright's stain,  according to  the method previously described. 
In such specimens platelets are found in numbers lying in the capil- 
laries,  singly or  in  groups,  and  also  in  the  larger  vessels  scattered 
among the red corpuscles.  They are very distinct on account of their 
characteristic staining.  One cannot overlook them or mistake them 
for any of the other elements present.  In addition one finds here and 
there in the preparation, in amounts that vary with conditions, what 
may be  called  platelet  masses  or  platelet  processes  containing  the 
characteristic red-purple platelet granules.  These processes are of all 
sizes and shapes.  Sometimes small oval bodies that might be desig- 
nated  as  giant platelets,  but  frequently very large  masses,  or long 
strings lying in the capillaries (Fig. 7). 194  PRODUCTION  OF BLOOD  PLATELETS IN LUNGS 
These processes  or masses are not agglutinated platelets.  The platelet gran- 
ules are dispersed uniformly and not gathered into groups, as in the case of masses 
of agglutinated platelets.  Their histology and  the results of our examinations 
indicate that they are cast off pseudopodia or processes from the cytoplasm of the 
giant cells.  They form a striking feature in sections  of the lungs, particularly in 
the lungs of animals in which  the process of platelet production has been acceler- 
ated by experimental methods, but they are present also in the lungs of normal 
animals, sometimes scanty, sometimes quite abundant.  Their presence seems not 
to have been noted by most writers, but Bunting  (1911) calls attention to their 
occurrence in the lung of the rabbit, under conditions of accelerated platelet pro- 
duction, as also in the circulating blood in Hodgkin's disease.  In the marrow or, 
under some conditions,  in the spleen  similar detached platelet processes may be 
seen, but usually in the immediate neighborhood of a megacaryocyte, so that there 
may be a question as to whether they are really thrown off pseudopodia from a 
giant cell or whether the plane of the section has been such as to cut them off from 
the cytoplasm of the cell.  In the lungs this doubt does not arise, the processes lie 
free in the blood vessels wholy separate from the giant cells. 
The Giant Cells, Megacaryocytes, of the Lungs 
The  presence of giant  cells in  the  lungs  has been  noted  by many 
authors since they were first described and discussed by Aschoff.  In 
most cases they are described as naked and degenerating nuclei with- 
out  cytoplasmic  material,  although  Aschoff  himself  speaks  of  the 
occurrence of some cells with  surrounding  cytoplasm, and  Bianchini 
also refers to  the presence of megacaryocytes with surrounding  cyto- 
plasm filled with azurophilic granules.  The general opinion, however, 
has been that the giant cells in the lungs are migrants from the bone 
marrow (or spleen)  which have lost their cytoplasm in the process of 
platelet  formation before reaching  the  lungs,  or  in  any  case  shortly 
after being caught in the lung capillaries, so that they appear usually 
as  naked  and  degenerating  nuclei,  exhibiting  evidence  of  pycnosis. 
The results of our study lead us to an entirely different view. 
In the lung of the normal animal (the catwas used chiefly in our observations 
although corroborative results were obtained from the dog)  giant cells are found 
in the sections in all cases, but in variable numbers, depending on the animal or 
possibly the luck of the section.  In some cases in the normal cat they were quite 
numerous,  as many, for example, as forty to an area of  100  sq.  ram.  Under 
experimental conditions,  which caused an accelerated production of platelets, the 
number of giant cells in the lungs might be at least four times as great.  They 
differ greatly in appearance.  Some of them, perhaps most of them under ordinary W.  H.  HOWELL  AND  D.  D.  DONAR-UE  19~ 
conditions, are the so called naked nuclei with no appearance of cytoplasm.  Petri 
contends that they always show a  small protoplasmic non-granular zone, sharply 
bordered, and in our preparations there seemed to be at times a narrow basic rim 
of cytoplasm, and in cases  when  a  nucleus could be followed through serial sec- 
tions, what seemed to be a  naked nucleus might be found to have cytoplasmic 
process attached to some part of its periphery.  In very many cases what would 
ordinarily be called a naked nucleus showed caps of cytoplasmic material at the 
ends of the elongated or branched nucleus, the caps being composed of platelet 
material containing purplish red granules which stood out in marked contrast to 
the blue nucleus.  It seems probable that with stains that do not bring out the 
platelet granules  these  short processes of  cytoplasm would be  overlooked.  In 
some cases nuclei of this type predominated and gave the impression of cells that 
might be in a state of active production of platelet material, the processes being 
cast off rapidly to form platelets. 
In addition to this type of giant cell one finds in the lung of the normal animal 
and especially in the lung of animals in which platelet production had been accel- 
erated, giant cell nuclei with  one  or more cytoplasmic processes attached,  the 
processes  being  composed  entirely of  platelet material with  its  characteristic 
granules (Figs. 1 to 6).  The processes varied greatly in size and shape and number; 
sometimes  a  single finger-shaped projection from  one  pole  of  the  nucleus,  or 
extending out from each of the several poles of a  branched nucleus, sometimes 
very massive processes that entirely filled the capillary or small vessel in which 
they lay, and at other times a long branching process that penetrated the capil- 
laries for a  considerable distance, showing constrictions and  swellings along its 
course.  Owing to the frequently twisted shape of the nucleus and the projection 
of the cytoplasmic processes in different planes, it would be more or less a  happy 
accident to get a section through any one giant cell of this character that would 
show its entire outline.  Some of these cells show a quite extraordinary wealth of 
cytoplasmic processes pushing  through  the  capillaries in  many  directions.  As 
stated previously these processes are made up entirely of platelet material and are 
identical in  appearance with  the  platelets themselves,  and  with  the  detached 
processes or masses found scattered through the blood vessels of the lungs.  There 
would seem to be no doubt that these latter are broken off or detached processes of 
the giant cells and that by constriction or fragmentation they give rise to platelets. 
In general the giant cells of the lungs are different in appearance from the typical 
megacaryocyte with its crown or basket nucleus as found in the marrow or spleen. 
It is very rare, indeed, to find one with the nucleus placed centrally in the cyto- 
plasm and showing a  distinct lobulated or polymorphic appearance.  Usually the 
nucleus is an elongated oval or is pulled out into a Y  or branched form, and the 
cytoplasm springs from the ends or from separate points along the sides.  The 
nucleus  sometimes  shows  evidence of  a  polymorphic form  but  in  other  cases 
appears like a  greatly enlarged single nucleus.  In our preparations these nuclei 
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throughout with the basic dye (blue) there is no indication of pycnosis.  We have 
seen distinctly degenerating nuclei with pycnotic staining more frequently in the 
giant cells  of the marrow than in those of the lungs. 
The  giant  cells of the lungs  whether naked or with  cytoplasmic 
processes have the appearance of active growing cells, and there can 
be no doubt that the cytoplasm consists of platelet material and gives 
origin to circulating platelets.  The figures that we have reported in 
regard to the number of platelets in arterial and venous blood would 
seem to show that platelets are produced in the lungs.  Granting that 
the blood does receive an accession of platelets in passing through the 
lungs, the histological examination gives no indication of a  source of 
this platelet production other than from the cytoplasm of the giant 
cells. 
The Origin of the Megacaryo6ytes of the Lungs 
The prevalent view is that first suggested by Aschoff, namely, that 
the giant cells of the lungs are migrants from the bone marrow, or in 
the  newly born  or  very young animal  from the  spleen.  They are 
supposed to  escape into  the circulation and become trapped  in  the 
capillaries of the lungs.  No very good direct proof has been furnished 
for this view.  The possibility, however, that such a  migration may 
occur is indicated by the fact that in a variety of pathological condi- 
tions,  especially in myelogenous leucemia, megacaryocytes are found 
in the circulating blood.  It is stated also that conditions, experimental 
or pathological, which tend to increase the number or activity of the 
megacaryocytes of the marrow bring about a  parallel increase in the 
giant cells of the lungs.  This, however, is not conclusive proof of the 
migration theory, since it seems obvious that conditions which stimu- 
late the multiplication or functional activity of megacaryocytes might 
affect those in the lungs as well as those in the marrow.  In sections of 
the marrow or .the spleen one may find occasionally a  mature mega- 
caryocyte lying free in a large vein, in a position to be swept on into 
the circulation, and this fact may be accepted as indicating the pos- 
sibility of an escape of these cells from the marrow or spleen, although 
in itself it  can scarcely serve as a  demonstration that all the mega- 
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that if this origin is accepted it does not follow that the giant cells of 
the lungs are on the way to degeneration and play no functional r61e. 
Our observations indicate on the contrary that in their new environ- 
ment they are active in the production of platelets and give no indica- 
tion  of  degenerative  changes.  The  histological evidence for  their 
participation in platelet formation is in fact more convincing than in 
the case of the marrow.  So called Wright's figures are not always 
conspicuously in evidence in sections of the marrow, whereas in the 
lungs giant cells found with cytoplasmic processes are quite obviously 
engaged in the manufacture of platelets. 
The  alternative  view  to  the migration theory is  that  the mega- 
caryocytes are formed or developed in the lungs themselves.  Some 
authors have taken this position.  The results of our studies lead us 
to adopt this view, since the number of giant cells found at times in 
the lungs,  and  their  evident activity in the production of platelets, 
hardly seems consistent with the theory that they are degenerating 
cells that have been cast off from the marrow. 
It is usually assumed that the lung capillaries have a special tend- 
ency  to  hold back  foreign material  in  the  circulation,  and  would, 
therefore, be likely to  filter out giant cells, if present.  This belief 
was not supported by direct experiments.  Freshly prepared emulsions 
of bone marrow were injected into the pulmonary artery, or one of its 
branches.  On subsequent examination of the lung tissue, treated in 
this way and preserved and stained by the methods described, we could 
not satisfy ourselves that there was any increase in the number of 
megacaryocytes present, and those that were found did not exhibit 
the characteristics of the marrow cells with their distinctive nucleus 
and surrounding cytoplasm; they  all belonged to  the type usually 
present in the lungs. 
The origin of the megacaryocyte is a much discussed question con- 
cerning which many  different opinions have  been  expressed.  Our 
study of the cell as it is found in the lungs, marrow, spleen, and liver at 
different ages and under different conditions has  led  us  to  accept 
the view proposed by Naegeli that they develop from a myeloblastic 
cell, which in its youngest stage possesses a clear nucleus with a con- 
spicuous nucleolus and a narrow rim of cytoplasm that takes a deep 
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to be transitional forms between this cell and the young or immature 
form of the megacaryocyte with its large nucleus, single or lobulated, 
and its small zone of non-granular basic cytoplasm.  In sections of 
the lungs, especially in  those animals in  which platelet production 
has been stimulated by defibrination of the blood or by the injection 
of peptone solutions, similar myeloblastic or lymphoblastic cells are 
found in numbers.  They lie free in the capillaries much as they do in 
the liver capillaries of the fetus.  They exhibit a great variety in size 
and shape.  Transitional forms or what seem to be transitional forms 
between it and the giant cell of the lung may be found in which the 
nucleus is  greatly  enlarged and  the  cytoplasm begins to  show the 
appearance of granules and takes a purplish stain.  The origin of these 
myeloblastic cells is not evident.  They are found in connection with 
megacaryocytes in the liver of the fetus, in the spleen, the marrow, and 
the lungs.  When conditions are such as to le~d to an increase in the 
number of megacaryocytes in the lungs there is a  corresponding in- 
crease in number of these cells.  In the lung of the embryo cat near 
term, or in the newly born kitten, when giant cells are just beginning 
to appear in the lungs, some of these myeloblastic cells will be found. 
In the kitten of 1 or 2 months, when the number of giant cells in the 
lungs is noticeably increased, the myeloblastic cells are conspicuous 
on account of their number and their apparent activity, as indicated 
by  their  large  size  and  varying  shapes.  The  histological  picture 
indicates a  relationship between these cells and the megacaryocytes 
and tends to support the theory that the giant ceils develop from them 
in the lungs after birth, as they do in the liver before birth. 
Megacaryocytes  of the Bone Marrow and Other  Tissues 
Most of the authors who have studied the subject (Bunting, Ogata, 
Di Guglielmo, Kuczynski, Cesaris-Demel, Firket, Bianchini, Downey, 
Minot, Sabin, et al.) have accepted the theory of Wright that the blood 
platelets  are  produced from the  cytoplasm of the megacaryocytes, 
and  that in  the adult  animal this process takes place in  the bone 
marrow.  Sections of the marrow of the cat  (femur), preserved and 
stained  by  the  methods  described,  give  excellent  examples  of  the 
appearances described by Wright.  The megacaryocytes are present 
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the cytoplasm is filled with granules that stain like those in the blood 
platelets, and frequently the cytoplasm sends out processes or pseudo- 
podia which at times penetrate into the blood channels.  The picture 
as a  whole can scarcely be given any other interpretation than that 
proposed by Wright.  There are, however, some known facts which, 
on the surface, at least, seem to be at variance with this interpretation, 
so  far  as  the  marrow  is  concerned.  In  sections  or  smears  of  the 
marrow few platelets are found.  They are noticeably less numerous 
than in the lungs or spleen, and are fewer in number than would be 
expected on the theory that they are being constantly produced by the 
marrow megacaryocytes.  Cramer and Drew have commented upon 
this fact, and it will be remembered that in our perfusion experiments 
which included the bone marrow, as in those of Drinker and Drinker 
in which the marrow alone was perfused, the e~uent was very deficient 
in platelets.  There was no indication of a supply of these elements in 
the marrow comparable  to  that  found for the lungs.  Clinical  and 
experimental data  reported from various  sources indicate a  lack of 
correlation  between  platelets  and  marrow  megacaryocytes.  The 
platelets may be  reduced greatly in  number or  entirely eliminated 
with  no  obvious  change in  the  number of megacaryocytes, or  the 
marrow may show no megacaryocytes while the blood stiU contains 
platelets (Bianchini, Barbieri, Filo, Lawrence and Mahoney, Stebbins 
and Cams, Willi).  Observations of this kind indicate the existence of 
some unknown factors bearing  upon  the  relationship  of the  mega- 
caryocytes of the marrow to  the blood  platelets.  The participation 
of the lungs in the process of platelet production is one such factor 
that has not been considered heretofore. 
On the histological side alone the connection of the mature form of 
megacaryocyte with platelet formation seems so convincing that one 
may assume that wherever such cells occur they are capable of dis- 
charging this function.  As is well known megacaryocytes are found in 
several organs, and in the course of development of the fetus a certain 
sequence is observed.  They appear first in the liver and subsequently 
in the spleen and marrow.  We have been able to follow this march in 
the case of the cat. 
In a fetus of about 80 nun. they are just beginning to appear in the marrow of the 
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that platelet granules are not present.  In the liver and the spleen, however, fully 
developed megacaryocytes are found, those of the liver giving evidence of greater 
activity, as indicated by the number that contain fully matured platelet granules 
in the cytoplasm.  The lungs at this age contain no giant cells.  In the circulation 
blood platelets are present although few in number.  If the theory that they are 
formed by megacaryocytes is sound,  then at this time only the giant cells of the 
liver and spleen take part in the process.  In an older embryo, 115 mm:, not far 
from term,  the  megacaryocytes in  the  liver and  spleen  were  distinctly  more 
numerous and the presence of processes of the cytoplasm indicated a greater degree 
of activity, but the maximum focus of activity still appeared to be in the liver. 
The number of platelets in the blood was increased, reaching a figure of 55,000 per 
c.mm. for a red cell count of 4,500,000.  In the marrow of the femur the number 
of giant cells was distinctly greater than in the fetus of 80 ram. as determined from 
longitudinal sections  through the entire bone.  Toward the middle of the shaft 
some were found in which platelet granules we#e present in the cytoplasm. 
At birth and shortly afterward the liver still contains megacaryocytes, but some 
of them show signs of degeneration in the nucleus,  and the seat of activity has 
quite evidently been transferred to the spleen and the marrow.  In the lungs at 
this time megacaryocytes begin to appear,  a  few being found in  each section. 
Finally in an examination made of a cat approximately 2 months old the giant cells 
of the marrow were numerous and resembled those of the adult in variety and in 
evidences of activity, and in the lungs their number was distinctly larger than in 
the newly born animal.  In the spleen, on the contrary, no megacaryocytes could 
be found. 
In  general,  it may be said,  for the  cat,  that  several months  after 
birth  and  in  the  adult  animal  the megacaryocytes are  concentrated 
chiefly in the marrow and the lungs.  In the marrow the histological 
picture indicates active platelet production, but this inference is not 
supported  satisfactorily  by  the  experimental  results  obtained  from 
perfusions of the marrow and from actual platelet counts in the venous 
blood returning from the marrow.  In the lungs, on the other hand, 
the histological evidence for active platelet formation by the giant cells 
is confirmed by the experimental results described in this paper,  and 
one is justified in believing that the lungs constitute the main source 
of platelet production. 
The  functional  relationship  between  the  megacaryocytes  of  the 
lungs and those of the marrow is uncertain.  Three possibilities may 
be  considered.  First,  the  megacaryocytes of  the  lungs  may be  ex- 
plained,  in  accordance with  the  usual  view,  as  migrants  or  emboli 
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caught mechanically in the lungs where they remain until degeneration 
and disintegration occur.  We have given reasons for believing that 
this view does not fit the facts in the case.  Second, it may be sup- 
posed that the megacaryocytes of the marrow after reaching a certain 
degree of maturity migrate to  the lungs where, under different and 
presumably more favorable environmental conditions, they enter into 
full  activity.  This  view  assumes  a  mechanism  of  adjustment  or 
accommodation for which there is no evidence and which seems to be 
intrinsically improbable, and it implies also a  more or less constant 
transfer of megacaryocytes from marrow to lungs which is not borne 
out  by  the  results  of blood  examinations.  The  third  view,  which 
seems to us the most probable, is that the lung megacaryocytes  develop 
in the lungs from myeloblastic cells in the same manner that they do 
in the liver, spleen, and marrow.  The reasons for the transfer of mega- 
caryocytic activity from liver to spleen, and from spleen to marrow 
in the early stages of life are not apparent, but there seems to be no 
question that it takes place.  In the same sense we may believe that 
in extrauterine life the conditions favor the development of these cells 
in the marrow and the lungs, and the experimental facts indicate that 
the place of greatest functional activity is in the lungs.  On the his- 
tological evidence, however, one must admit that the megacaryocyte 
wherever found has the function or the potential function of producing 
platelets from its cytoplasm.  It constitutes, so to speak, a  unicellar 
gland which gives off a  solid secretion in the form of platelets.  The 
eventual solution or disintegration of the platelets presumably adds 
to the plasma important constituents the nature and significance of 
which are at present not definitely known. 
1.  A new fixing solution is described, which preserves the platelets 
and prevents contact hemolysis of the erythrocytes, so that counts of 
both corpuscles may be made in the same preparation. 
2.  Comparative counts of platelets in arteries and veins show that 
arterial blood contains a larger number of platelets than venous blood. 
This  difference is  accentuated  under  experimental  conditions  that 
cause a  reduction in  the number of platelets.  It is  concluded that 
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and that there is a corresponding destruction of platelets as the blood 
passes through the capillary areas of the systemic circulation. 
3.  Perfusion of the lungs with a  platelet-preserving solution, com- 
pared with that of other organs, gives evidence of the existence of a 
source of platelet material in the lungs. 
4.  Histological examination of the lungs with a technique adequate 
to  give a  differential staining of platelet material demonstrates the 
presence of giant cells in the lungs, and supports the view that they 
are active in the production of platelets. 
5.  In extrauterine life giant cells  are concentrated in the marrow 
and the lungs, with the maximum of their activity in platelet produc- 
tion in the lungs. 
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EXPLANATION OF PLATE 6 
Megacaryocytes from the lungs of the cat, showing the character of the platelet 
processes.  From camera lucida drawings. 
FIGS. 1, 2, 3, 4, and 5.  From the lung of a cat 5 days after partial  defibrination 
of the blood. 
FxG. 6.  From the lung of a normal animal. 
FIG. 7.  An example of the detached platelet processes lying free in the capil- 
laries--specimen from lung of normal animal. THE JOURNAL OF EXPERIMENTAL MEDICINE VOL. 65  PLATE  6 
(Howell and Donahue: Production of  blood platelcts  in  lungs) 